BDSX

14.81

0.80% -0.12

Handel nachbörslich: 14.81

Biodesix Inc (BDSX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$14.93

Offen:

$15.1

24-Stunden-Volumen:

29,964

Relative Volume:

0.32

Marktkapitalisierung:

$153.37M

Einnahmen:

$88.50M

Nettoeinkommen (Verlust:

$-35.27M

KGV:

-4.4941

EPS:

-3.2954

Netto-Cashflow:

$-23.70M

1W Leistung:

+6.24%

1M Leistung:

+39.19%

6M Leistung:

+88.18%

1J Leistung:

+116.14%

1-Tages-Spanne:

$14.24

$15.10

1-Wochen-Bereich:

$13.90

$15.44

52-Wochen-Spanne:

$5.00

$20.21

Biodesix Inc Stock (BDSX) Company Profile

Firmenname

Biodesix Inc

Sektor

Healthcare (1111)

Branche

Diagnostics & Research (52)

Telefon

303-417-0500

Adresse

919 WEST DILLON ROAD, LOUISVILLE

Mitarbeiter

334

Twitter

Nächster Verdiensttermin

2026-05-04

Neueste SEC-Einreichungen

BDSX's Discussions on Twitter

Compare BDSX vs TMO, DHR, IDXX, WAT, A

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BDSX Biodesix Inc	14.81	154.61M	88.50M	-35.27M	-23.70M	-3.2954
TMO Thermo Fisher Scientific Inc	448.18	166.59B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	172.81	121.74B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	557.21	44.12B	4.45B	1.10B	1.06B	13.59
WAT Waters Corp	338.64	33.62B	3.77B	449.25M	240.68M	7.8556
A Agilent Technologies Inc	115.08	32.49B	7.07B	1.29B	993.00M	4.5355

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-27	Hochstufung	William Blair	Mkt Perform → Outperform
2025-05-14	Herabstufung	William Blair	Outperform → Mkt Perform
2024-09-16	Eingeleitet	Scotiabank	Sector Outperform
2024-07-26	Eingeleitet	Craig Hallum	Buy
2024-05-13	Eingeleitet	TD Cowen	Buy
2024-05-03	Eingeleitet	Lake Street	Buy
2021-11-17	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-11-23	Eingeleitet	BTIG Research	Buy
2020-11-23	Eingeleitet	Canaccord Genuity	Buy
2020-11-23	Eingeleitet	Morgan Stanley	Overweight
2020-11-23	Eingeleitet	William Blair	Outperform

Alle ansehen

Biodesix Inc Aktie (BDSX) Neueste Nachrichten

May 25, 2026

Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade - Zacks Investment Research

May 25, 2026

May 23, 2026

Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue Assumptions - Insider Monkey

May 23, 2026

May 22, 2026

BDSX Stock Price, Quote & Chart | BIODESIX INC (NASDAQ:BDSX) - ChartMill

May 22, 2026

May 21, 2026

Biodesix (NASDAQ: BDSX) registers 375,000 shares for Perceptive resale - Stock Titan

May 21, 2026

Biodesix meets investors in Minneapolis, Chicago and Dana Point - Stock Titan

May 21, 2026

Biodesix to Participate in Upcoming Investor Conferences - Caledonian Record

May 21, 2026

May 20, 2026

Biodesix shareholders elect directors and approve executive compensation By Investing.com - Investing.com Australia

May 20, 2026

Biodesix shareholders elect directors and approve executive compensation - Investing.com

May 20, 2026

Biodesix Shareholders Approve Directors and Governance Measures - TipRanks

May 20, 2026

Biodesix (NASDAQ: BDSX) holders back directors, pay and KPMG auditor - Stock Titan

May 20, 2026

May 15, 2026

Perceptive entities disclose 4.6% holding in Biodesix (NASDAQ: BDSX) - Stock Titan

May 15, 2026

May 13, 2026

Biodesix BDSX Q2 2025 Earnings Call Transcript - AOL.com

May 13, 2026

May 11, 2026

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy - The Manila Times

May 11, 2026

Blood test for lung nodules gets real-world spotlight at ATS 2026 - Stock Titan

May 11, 2026

Biodesix to present new real-world data on Nodify Lung testing at ATS 2026, highlighting clinical and economic benefits. - Pluang

May 11, 2026

May 09, 2026

Does Biodesix (BDSX) have the potential to rally 103.33% as Wall Street analysts expect? - MSN

May 09, 2026

May 08, 2026

Biodesix (NASDAQ: BDSX) holder Soleus reports 416,599 shares (4.1%) - Stock Titan

May 08, 2026

Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect? - Yahoo Finance

May 07, 2026

May 06, 2026

Biodesix Earnings Call Signals Strong Growth Momentum - The Globe and Mail

May 06, 2026

Biodesix Faces Mounting Reimbursement and Enforcement Risks as Evolving Payer Policies Threaten Revenue Stability - TipRanks

May 06, 2026

May 05, 2026

TD Cowen Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $30 - Moomoo

May 05, 2026

MSN Money - MSN

May 05, 2026

Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock Price - MarketBeat

May 05, 2026

Biodesix touts ‘clear path toward profitability’ - BizWest

May 05, 2026

William Blair Maintains Biodesix(BDSX.US) With Buy Rating - Moomoo

May 05, 2026

Lake Street Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $40 - Moomoo

May 05, 2026

CCORF Maintains Biodesix(BDSX.US) With Buy Rating, Raises Target Price to $22 - Moomoo

May 05, 2026

Biodesix Inc. 10-Q Q1 2026: Financial Statements, Risk Factors, and Management Analysis - Minichart

May 05, 2026

Biodesix stock price target raised to $22 by Canaccord on revenue growth - Investing.com

May 05, 2026

Biodesix, Inc. (NASDAQ:BDSX) Q1 2026 Earnings Call Transcript - Insider Monkey

May 05, 2026

Biodesix (BDSX) Q1 2026 Earnings Transcript - AOL.com

May 05, 2026

May 04, 2026

Biodesix, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 04, 2026

Biodesix Q1 Earnings Call Highlights - MarketBeat

May 04, 2026

BDSX Financials: Income Statement, Balance Sheet & Cash Flow | BIODESIX INC - Stock Titan

May 04, 2026

BDSX: Q1 revenue up 42% year-over-year, with raised 2026 guidance and margin expansion - TradingView

May 04, 2026

Biodesix Q1 2026 Earnings Call: Complete Transcript - Benzinga

May 04, 2026

Earnings call transcript: Biodesix Q1 2026 shows revenue growth, stock steady - Investing.com

May 04, 2026